ASCO Cancer Foundation Awards $25,000 to Young Researchers


The ASCO Cancer Foundation Merit Awards are designed to promote clinical cancer research by young scientists.

ORLANDO, FL—The ASCO Cancer Foundation will present Merit Awards to 25 leading oncology fellows from around the world at the 2010 Gastrointestinal (GI) Cancers Symposium. According to L. Gunderson, MD, chair of the GI Symposium Steering Committee, “The future of clinical cancer research rests in our young leaders and we are honored to recognize this year’s Merit Award recipients for their dedication and contributions.” He added, “We hope these awards will help advance their commitment to improving care and quality of life for people living with gastrointestinal cancers.”

The ASCO Cancer Foundation Merit Awards, which are supported through restricted educational grants from Novartis Oncology, OSI Pharmaceuticals, Pfizer Oncology, and Sanofi-Aventis are designed to promote clinical cancer research by young scientists. This year’s awardees were selected based on the scientific merit of their abstracts. The 2010 ASCO Cancer Foundation Merit Award recipients are:

Thomas Winder, MD

University of Southern California Norris Comprehensive Cancer Center

Winson Y. Cheung, MD, MPH

Division of Medical Oncology, British Columbia Cancer Agency

Ajay V. Maker, MD

Memorial Sloan-Kettering Cancer Center

Kavitha P. Raj, MD

University of California, Irvine

Ewout F.W. Courrech Staal, MD

The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital

Shaun P. Mckenzie, MD

City of Hope National Medical Center

Cecile Ortholan, MD

Centre Antoine-Lacassagne

Maria Simona Pino, MD

Massachusetts General Hospital

Yasir M. Akmal, MD

City of Hope National Medical Center

Benjamin P. Negin, MD

Fox Chase Cancer Center

Anne Marie Espinoza, MD

University of California, San Francisco

Ioannis T. Konstantinidis, MD

Massachusetts General Hospital

Anubha Bharthuar, MD

Roswell Park Cancer Institute

Chakri Panjala, MD

Mayo Clinic

Rachna T. Shroff, MD

University of Texas M. D. Anderson Cancer Center

Yongping Liu, MD

Clinical Oncology Laboratory, Changzhou Tumor Hospital Affiliated to Medical School of Suzhou University

Sujatha Nallapareddy, MD

University of Colorado Denver

Ann Tan, MD

Cleveland Clinic Foundation

Suresh Chand Sanchetee, MD, MBBS

Rajasthan Cancer Cure Hospital

Terence Marques Williams, MD, PhD

University of Michigan

Maria Yi Ho, MD

British Columbia Cancer Agency

Xin-Rong Yang

Liver Cancer Institute, Zhong Shan Hospital and Shanghai Medical School, Fudan University

Peter Joel Hosein, MD

University of Miami Sylvester Comprehensive Cancer Center

Jason Michael Samuelian, BS

Mayo Clinic Arizona

Debashish Bose, MD, PhD

The University of Texas M. D. Anderson Cancer Center

The full press release can be viewed here.

Related Videos
Connective Tissue Disease Brings Dermatology & Rheumatology Together
What Makes JAK Inhibitors Safe in Dermatology
Potential JAK Inhibitor Combination Regimens in Dermatology
Therapies in Development for Hidradenitis Suppurativa
"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology
Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH
Ghada Bourjeily, MD: Research Gaps on Sleep Issues During Pregnancy
John Winkelman, MD, PhD: When to Use Low-Dose Opioids for Restless Legs Syndrome
© 2024 MJH Life Sciences

All rights reserved.